ABT-199 and TRU-016 from ASH 2013 with Dr. Pagel

Hi friends

Dr. John Pagel discusses the risks and benefits of ABT-199 and TRU-016 in CLL (chronic lymphocytic leukemia) in an interview from ASH 2013 that I just posted on my blog bkoffman.blogspot.com

I am off to ASCO later this week with an absolutely crazy schedule of interviews, lectures and meetings that I want to bring to the CLL community over the ensuing months.

Stay strong.

Brian

oldestnewest

You may also like...